SB
EVH icon

Suntrust Banks’s Evolent Health EVH Stock Holding History

Suntrust Banks’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-18,196
Closed -$517K – 1292
2018
Q3 		$517K Buy
18,196
+300
+2% +$7.16K ﹤0.01% 908
2018
Q2 		$377K Buy
+17,896
New +$339K ﹤0.01% 1018

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Suntrust Banks's EVH Position: Q4 2018 in Review

Suntrust Banks sold out of Evolent Health (EVH) in Q4 2018, closing a stake of 18,196 shares — an estimated $517K sold.

Suntrust Banks first reported a position in EVH in Q2 2018 and held it in 2 quarters. The position peaked at $517K in Q3 2018. 186 funds tracked by Wall St. Rank hold EVH as of Q4 2018.

  • Suntrust Banks reported no remaining Evolent Health position as of Q4 2018 after selling out during the quarter.
  • Suntrust Banks sold 18,196 Evolent Health shares in Q4 2018, an estimated $517K.
  • Suntrust Banks first reported a position in Evolent Health in Q2 2018 and held it in 2 quarters.
  • Suntrust Banks's Evolent Health position peaked at $517K in Q3 2018.
  • 186 funds tracked by Wall St. Rank held Evolent Health as of Q4 2018.

Based on Suntrust Banks's 13F filing for Q4 2018, filed 14 Feb 2019.